<DOC>
	<DOC>NCT00736502</DOC>
	<brief_summary>The aim of this trial is to evaluate the safety and virological and immunological efficacy of ViramuneÂ® on a background of different antiretroviral drug combinations.</brief_summary>
	<brief_title>PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion criteria: The inclusion criteria follow the same criteria which are describe in the newest SPC. Exclusion criteria: The exclusion criteria follow the same criteria which are describe in the newest SPC.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>